INS and Insulin resistance: Secondary outcomes were changes in insulin AUC, insulin resistance assessed using the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), β-cell function (HOMA-β), Matsuda Insulin Sensitivity Index, cardiometabolic risk markers and autophagy gene expression.